Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1981-12-03
1989-04-18
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540355, C07D20508, C07D41712, A61K 31395, A61K 31425
Patent
active
048227900
ABSTRACT:
Disclosed are compounds of the general formula: ##STR1## wherein R.sub.1 is amino, an acylated amino or a protected amino group, X is hydrogen or methoxy, and R' is hydrogen, R or R.sup.4 where R is an organic residue attached to the azetidine ring through a carbon atom therein and R.sub.4 is azido, a halogen, an amino group which may optionally be acylated or a group of the formula ##STR2## wherein R.sub.5 is an organic residue and n is 0, 1 or 2, and pharmaceutically acceptable salts and esters thereof.
The compounds have antimicrobial and/or .beta.-lactamase-inhibitory activity and are of value as drugs for human beings and domesticated animals.
REFERENCES:
patent: 4225586 (1980-09-01), Imada et al.
patent: 4229436 (1980-10-01), Imada et al.
Clauss et al., Annalen der Chemie, 1974, pp. 539-560.
Matsuo Taisuke
Ochiai Michihiko
Berch Mark L.
Takeda Chemical Industries Ltd.
LandOfFree
1-Sulfo-2-oxoazetidine derivatives and their production does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-Sulfo-2-oxoazetidine derivatives and their production, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-Sulfo-2-oxoazetidine derivatives and their production will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2397073